Harvard Apparatus Regenerative Technology, Inc.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $704.0K | $430.0K | $103.0K | $0 | $0 | $0 | $0 | $0 |
| Cost of Revenue | $646.0K | $270.0K | $24.0K | — | — | — | — | $0 |
| Gross Profit | $58.0K | $160.0K | $79.0K | — | — | — | — | $0 |
| Gross Margin | 8.2% | 37.2% | 76.7% | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | $2.7M | $2.3M | $3.1M | $1.6M | $2.1M | $4.9M | $3.9M | $7.6M |
| SG&A Expense | $4.3M | $5.0M | $5.7M | $7.0M | $3.3M | $4.0M | $3.9M | $3.9M |
| Operating Income | $-6.9M | $-7.7M | $-9.0M | $-8.6M | $-5.3M | $-8.9M | $-7.8M | $-11.5M |
| Operating Margin | -982.2% | -1,796.7% | -8,728.2% | — | — | — | — | — |
| Interest Expense | — | — | $14.0K | — | — | — | — | — |
| Pretax Income | $-6.9M | $-7.7M | — | — | — | — | — | $-11.9M |
| Income Tax Expense | $0 | $0 | — | — | — | $0 | $0 | $0 |
| Net Income | $-6.9M | $-7.7M | $-8.9M | $-8.0M | $-4.9M | $-8.3M | $-7.5M | $-11.9M |
| Net Margin | -975.7% | -1,798.1% | -8,684.5% | — | — | — | — | — |
| EPS (Basic) | $-0.42 | $-0.52 | $-0.67 | $-0.79 | $-0.55 | $-1.21 | $-1.69 | $-6.63 |
| EPS (Diluted) | — | — | $-0.67 | $-0.79 | $-0.55 | $-1.21 | $-1.69 | $-6.63 |
| Shares Outstanding (Basic) | 16.5M | 14.8M | 13.5M | 10.1M | 8.8M | 8.2M | 5.7M | 2.5M |
| Shares Outstanding (Diluted) | 16.5M | 14.8M | 13.5M | 10.1M | 8.8M | 8.2M | 5.7M | 2.5M |
| Dividends Per Share | — | — | — | — | — | — | — | — |